R. Oliveira

发表

Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial

F. Cunha, J. Alves-Filho, P. Louzada-Junior, 2020, medRxiv.

SARS-CoV-2 triggered neutrophil extracellular traps (NETs) mediate COVID-19 pathology

P. Saldiva, A. Fabro, F. Dal-Pizzol, 2020, medRxiv.

Interleukin-18, interleukin-12B and interferon-γ gene polymorphisms in Brazilian patients with rheumatoid arthritis: a pilot study.

E. Donadi, P. Louzada-Junior, S. Crovella, 2015, Tissue antigens.

PREVALENCE OF ANTI-TOXOPLASMA-GONDII ANTIBODIES IN PREGNANT WOMEN PREVALENCIA DE ANTICUERPO ANTI-TOXOPLASMA-GONDII EN MUJERES EMBARAZADAS

L. Albuquerque, J. Antonio, Inagaki, 2009 .

A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies.

E. Donadi, P. Louzada-Junior, M. Bértolo, 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

C. Del-Ben, P. Louzada-Junior, R. Luppino-Assad, 2023, Inflammation research : official journal of the European Histamine Research Society ... [et al.].